Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 3Zantac
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2019 Revenue in Millions : 85
2018 Revenue in Millions : 138
Growth (%) : -39
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2020 Revenue in Millions : -8
2019 Revenue in Millions : 94
Growth (%) : -109
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2018 Revenue in Millions : 144
2017 Revenue in Millions : 132
Growth (%) : 9%
LOOKING FOR A SUPPLIER?